{"categories":["FDA"],"blog_url":"https://uneyama.hatenadiary.jp/","version":"1.0","width":"100%","url":"https://uneyama.hatenadiary.jp/entry/20170808/p5","author_url":"https://blog.hatena.ne.jp/uneyama/","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20170808%2Fp5\" title=\"\u8b66\u544a\u6587\u66f8\u3002 - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","description":"Absonutrix 7/25/17 July 25, 2017 https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2017/ucm568862.htm \u672a\u627f\u8a8d\u306e\u533b\u85ac\u54c1\u3001\u8868\u793a\u9055\u53cd\u3002 God Quest, Inc. d/b/a Creation Today 6/29/17 June 29, 2017 https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2017/ucm568172.htm \u672a\u627f\u8a8d\u306e\u533b\u85ac\u54c1\u3001\u8868\u793a\u9055\u53cd\u3002 \u751f\u306e\u30a2\u30d7\u30ea\u30b3\u30c3\u30c8\u30ab\u30fc\u30cd\u30eb\u3092\u8ca9\u58f2\u3057\u3066\u3044\u308b\u30a6\u30a7\u30d6\u2026","provider_url":"https://hatena.blog","published":"2017-08-08 00:00:04","height":"190","title":"\u8b66\u544a\u6587\u66f8\u3002","author_name":"uneyama","type":"rich","image_url":null,"provider_name":"Hatena Blog"}